These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25535844)

  • 21. Vaccine administration decision making: the case of yellow fever vaccine.
    Lown BA; Chen LH; Wilson ME; Sisson E; Gershman M; Yanni E; Jentes ES; Hochberg NS; Hamer DH; Barnett ED
    Clin Infect Dis; 2012 Sep; 55(6):837-43. PubMed ID: 22670048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viscerotropic disease following yellow fever vaccination in Peru.
    Whittembury A; Ramirez G; Hernández H; Ropero AM; Waterman S; Ticona M; Brinton M; Uchuya J; Gershman M; Toledo W; Staples E; Campos C; Martínez M; Chang GJ; Cabezas C; Lanciotti R; Zaki S; Montgomery JM; Monath T; Hayes E
    Vaccine; 2009 Oct; 27(43):5974-81. PubMed ID: 19679215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of yellow fever vaccine in Indian travellers: A prospective observational study.
    Tiwari P; Ahlawat R; Gupta G
    Indian J Med Res; 2016 Nov; 144(5):778-780. PubMed ID: 28361832
    [No Abstract]   [Full Text] [Related]  

  • 24. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.
    Jentes ES; Poumerol G; Gershman MD; Hill DR; Lemarchand J; Lewis RF; Staples JE; Tomori O; Wilder-Smith A; Monath TP;
    Lancet Infect Dis; 2011 Aug; 11(8):622-32. PubMed ID: 21798462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Traveler's syndromes and medical repatriation].
    Nau JY
    Rev Med Suisse; 2013 Jun; 9(392):1398-9. PubMed ID: 23882922
    [No Abstract]   [Full Text] [Related]  

  • 26. Yellow fever in Brazil: Epidemiological aspects and implications for travelers.
    Chaves TDSS; Orduna T; Lepetic A; Macchi A; Verbanaz S; Risquez A; Perret C; Echazarreta S; Rodríguez-Morales AJ; Lloveras SC
    Travel Med Infect Dis; 2018; 23():1-3. PubMed ID: 29751132
    [No Abstract]   [Full Text] [Related]  

  • 27. Late vaccination against yellow fever of travelers visiting endemic countries.
    Krief I; Goldblatt JG; Paz A; Potasman I
    Travel Med Infect Dis; 2006 Mar; 4(2):94-8. PubMed ID: 16887731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yellow fever vaccination: is one dose always enough?
    Patel D; Simons H
    Travel Med Infect Dis; 2013; 11(5):266-73. PubMed ID: 24074827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of infections during travel abroad].
    Stickl H
    Fortschr Med; 1974 Jun; 92(16):685-90. PubMed ID: 4134967
    [No Abstract]   [Full Text] [Related]  

  • 30. The US-Certified Yellow Fever Vaccination Center Registry: a tool for travelers, state health departments, and vaccine providers.
    Russell MN; Cetron MS; Eidex RB
    J Travel Med; 2006; 13(1):48-9. PubMed ID: 16412108
    [No Abstract]   [Full Text] [Related]  

  • 31. [Efficacy and safety of vaccination against yellow fever of persons traveling to endemic areas].
    Dabrowska MM; Flisiak R
    Przegl Epidemiol; 2010; 64(2):319-22. PubMed ID: 20731245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yellow fever vaccine supply: a possible solution.
    Monath TP; Woodall JP; Gubler DJ; Yuill TM; Mackenzie JS; Martins RM; Reiter P; Heymann DL
    Lancet; 2016 Apr; 387(10028):1599-600. PubMed ID: 27116054
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical trial with unlicensed yellow fever vaccine in Japan.
    Ujiie M; Terada M; Kobayakawa M; Ohmagari N
    J Travel Med; 2019 Sep; 26(6):. PubMed ID: 30657930
    [No Abstract]   [Full Text] [Related]  

  • 34. Yellow fever and Hajj 2019: from airline introduction of mosquitoes to expanding geography of transmission and vaccination challenges.
    Ebrahim SH; Memish ZA
    J Travel Med; 2019 Sep; 26(6):. PubMed ID: 31321432
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccination Challenges in Confronting the Resurgent Threat From Yellow Fever.
    Chen LH; Hamer DH
    JAMA; 2017 Nov; 318(17):1651-1652. PubMed ID: 28983553
    [No Abstract]   [Full Text] [Related]  

  • 36. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection.
    Kengsakul K; Sathirapongsasuti K; Punyagupta S
    J Med Assoc Thai; 2002 Jan; 85(1):131-4. PubMed ID: 12075714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of the risks and benefits of yellow fever vaccination including some new analyses.
    Monath TP
    Expert Rev Vaccines; 2012 Apr; 11(4):427-48. PubMed ID: 22551029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yellow fever vaccination: how much is enough?
    Massad E; Coutinho FA; Burattini MN; Lopez LF; Struchiner CJ
    Vaccine; 2005 Jun; 23(30):3908-14. PubMed ID: 15917112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of yellow fever in persons traveling to the tropics.
    Monath TP; Cetron MS
    Clin Infect Dis; 2002 May; 34(10):1369-78. PubMed ID: 11981733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yellow fever recommendations for tourists to Kenya: a flawed risk assessment?
    Behrens RH
    J Travel Med; 2008; 15(5):285-6. PubMed ID: 19006499
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.